Cerity Partners’s Amicus Therapeutics FOLD Stock Holding History

Cerity Partners’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-58,090	Closed	-$840K	–	3468
2026 Q1	$840K	Sell	58,090 -4,991	-8%	-$71.5K	﹤0.01%	1956
2025 Q4	$898K	Buy	63,081 +27,801	+79%	+$273K	﹤0.01%	1764
2025 Q3	$278K	Buy	+35,280	New	+$251K	﹤0.01%	2331
2024 Q4	–	Sell	-10,152	Closed	-$108K	–	2489
2024 Q3	$108K	Sell	10,152 -4,123	-29%	-$44.9K	﹤0.01%	2416
2024 Q2	$142K	Sell	14,275 -1,883	-12%	-$19.3K	﹤0.01%	2076
2024 Q1	$190K	Buy	+16,158	New	+$207K	﹤0.01%	2122

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Cerity Partners's FOLD Position: Q2 2026 in Review

Cerity Partners sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 58,090 shares — an estimated $840K sold.

Cerity Partners first reported a position in FOLD in Q1 2024 and held it in 6 quarters. The position peaked at $898K in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Cerity Partners reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Cerity Partners sold 58,090 Amicus Therapeutics shares in Q2 2026, an estimated $840K.
Cerity Partners first reported a position in Amicus Therapeutics in Q1 2024 and held it in 6 quarters.
Cerity Partners's Amicus Therapeutics position peaked at $898K in Q4 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.